Navigation Links
HCT in Medical News

Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure

- Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies - Up to 80% of patients may need multiple medications to help them reach blood pressure goals - Single-pill combinations offer effective, ...

DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter

...iation, particularly for TSAT and ferritin. Hb and hct were affected by the day of the week blood was dra...e obtained the first dialysis day of the week. Hb, hct and Ret-H e /CHr values were measured using a Sysm...chieve clinically meaningful accuracy and that HB, hct and reticulocyte Hb (Ret-H e or CHr) were useful ...

Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill

... - Exforge hct combines a proven calcium channel blocker, angiote...) in one pill - In a clinical trial, Exforge hct demonstrated significantly greater reductions in s...essure and many need three or more - Exforge hct can help appropriate patients reach BP goals; offe...

Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008

...ons with peak widths less than 5 sec. The control by Bruker's Hystar™ software supports all proteomics applications on the maxis, micrOTOF-Q II, hct ion trap, Flex MALDI and apex FTMS instrument series for complete, turn-key LC/MS/MS solutions. The new Bruker mass spectrometry products and applicat...

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment

...end of March 2014, whereby Forest will receive a gradual reduction on profit percentage from its partner Daiichi Sankyo related to Benicar and Benicar hct sales. However, during this period the Benicar profit received will no longer be impacted by salesforce expense as the Company will reallocate those d...

JCI table of contents: Feb. 21, 2008

...c stem cell transplantation (HCT). However, little is known about effective hct approaches to treating individuals with solid tumors. In a new study, Richa...olleagues, at the National Institutes of Health, Bethesda, have outlined an hct approach for the treatment of metastatic kidney cancer that caused tumor re...

DaVita 4th Quarter 2007 Results

...t/V > 1.2 94.4% 93.6% 92.9% Patients with albumin >/= 3.5 83.7% 82.9% 84.0% Patients with hct >/= 33 82.4% 82.8% 84.7% (1) These are non-GAAP financial measures. For a reconciliation of these non-G...
HCT in Medical Technology

Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril

Comparison of BENICAR HCT 40/12.5 and 40/25 mg/day and Amlodipine + Benazepril 5/20 and 10/20 mg/day Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting PARSIPPANY, N.J., May 21, 2007 /PRNewswire/ -- New data presented today at the American Society of Hypertension...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

...gs to achieve their blood pressure goals. Tekturna hct is a single-pill combination of Tekturna((R)) (ali...edications. The FDA approval of Tekturna hct as initial therapy was based on clinical trial dat...pleased the FDA recognizes the benefit of Tekturna hct for the first-line treatment of patients with mode...

Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial

...eotech is developing based upon its first-in-class hct platform. A total of 60 patients were enrolled in ... DuraTech is the leading product in Osteotech's hct platform, which is based on Osteotech's breakthrou...ntroduce additional tissue products based upon its hct platform over the next several years that address ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

...iSILVER study found that BENICAR (R) and BENICAR hct (R) provided a mean reduction in 24-hour ambulato...sure (BP)-lowering efficacy of BENICAR and BENICAR hct in patients age 65 and older with mild to moderate...e, heart attack and stroke.(2) BENICAR and BENICAR hct are indicated for the treatment of hypertension. T...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

...nation with other antihypertensive agents. BENICAR hct is not indicated for initial therapy. BENICAR and BENICAR hct have not been FDA approved for other indications s...salt retention and increased blood volume. BENICAR hct combines BENICAR with the diuretic hydrochlorothia...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

...lood pressure (BP) of BENICAR hct (placebo: 43.1%). - Six out of 10 (cumulative 60....e to achieve a BP of BENICAR hct (placebo: 6.9%). PARSIPPANY, N.J., May 14 /PRNew...ed the ability of a regimen of BENICAR and BENICAR hct to lower blood pressure beyond 140/90 mm Hg to the...

NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has str...

NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...

NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012), in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...

NicOx' Naproxcinod ABPM Data Presented at American Heart Association

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...
HCT in Medical Products

STAT-CRIT HCT Instrument

Description: STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Company:Inverness Point of Care

STAT-CRIT Hct Analyzer

Description: STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Company:Wampole Laboratories

SafeCrit® Microhematocrit Tubes

Description:... easy to read SafeCrit plastic tubes, plain or heparinized. These tubes feature rapid capillary action and have a two-year shelf life. For use in RH12 hct rotor....
Company:Iris Sample Processing (formerly StatSpin, Inc.)

CritSpin Microhematocrit Centrifuge

Description:...ge of important benefits: - 2 minute spin, complete cell packing - Meets NCCLS standards - Read tubes in the rotor, less handling, less risk - Digital hct display reduces chance of error - Accepts glass or SafeCrit plastic tubes - Tube balancing not required, vibration free operation. Approval: C...
Company:Iris Sample Processing (formerly StatSpin, Inc.)
HCT in Biological Technology

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

...o received allogeneic hematopoietic cell transplants (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of hct that decreases the exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as interstitial pneumonitis. ...

Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement

...ring which Forest will have a residual participation in Benicar and Benicar hct profits, but will not be actively promoting those products. The result of t...mportant additional resources to build our franchise of Benicar and Benicar hct into significant products in the antihypertensive market while we built our...

Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement

...r blocker combination product, all indicated for the treatment of hypertension. * Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar hct are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Dar...

Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation

... in the United States under license from Merz Pharma GmbH & Co. KGaA of Germany. *Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar hct are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmst...

Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure

... - Tekturna hct combines first approved direct renin inhibitor wit...monly-used high blood pressure medicines. Tekturna hct is approved for patients not controlled by either ...Pennsylvania Hospital in Pittsburgh, PA. "Tekturna hct offers patients an effective new treatment option ...

One of Nation's Oldest Blood Services Providers Turns to Sysmex America

...ct fit for the blood processing center. The XE-2100D has an easy-to-use operating system and an extended platelet linearity of up to 5,000 x 10/ul and hct linearity up to 75%. Sysmex's state-of-the-art Interlaboratory Quality Control Program features a multi-level, all inclusive quality control material....

NicOx Opens U.S. Headquarters in New Jersey

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...

Schwartz leaves Merge board; will launch healthcare technology investment fund

...iding business development assistance to the company beyond his previously disclosed departure date of Sept. 1. "While the decision to launch a new hct fund requires me to resign from the board of directors, I plan to continue assisting the company in various new business development activities. It ha...

Analysis of Microarray Data

...man Cancer Institute cDNA microarray. mRNA or aRNA (2 g) was reverse transcribed in the presence of random ninemers and Cy dyes. hct 116 samples were labeled with Cy5-dCTP while RKO cells were labeled with Cy3-dCTP. Analysis of the microarray data was carried o...
Other Tags
(Date:6/2/2015)... April 8th, 2015, saw the transformation of ... “RockNRolla Movie Awards” EcoLuxe Lounge, a daylong event, sponsored ... the world’s top providers of ecologically sound and social ... Debbie Durkin, Los Angeles’ leading producer of sustainable product ... a premier red carpet event that makes appearances at ...
(Date:6/2/2015)... On Wednesday, May 27, 2015, professional driver, ... top speed of 207.9 mph. In the process, Hennessey’s ... the 200 mph mark. Jay Leno was on hand ... of Jay Leno’s Garage, which will air on CNBC later ... mile high speed oval at the Continental Tire Proving Grounds ...
(Date:6/2/2015)... Residents looking for a new dentist in ... convenient location now that Coast Dental Kissimmee is moving ... Irlo Bronson Memorial Highway, Suite C-106, Kissimmee, FL 34744. ... away from its original location, and features a beautiful, ... with digital intraoral and panoramic x-ray system and laser ...
(Date:6/2/2015)... Phoenix, AZ (PRWEB) June 02, 2015 The ... encouraged viewers to watch the station’s 6:00 a.m. Good Morning ... be entered on the station’s Facebook page. , ... other code-entering participants. She plans to apply the monthly ... months. Allen, a stay-at-home mom, expressed her surprise and ...
(Date:6/2/2015)... June 02, 2015 The term “Augmented ... generated imagery overlaid on the real world. Since then ... Visualization, which displays a map of the vasculature on ... growth in adoption. , AccuVein, the leader in vein ... year growth rate and such widespread adoption of its ...
Breaking Medicine News(10 mins):Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:Coast Dental Office Opening In Kissimmee with Expanded Technology 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2
(Date:5/27/2015)... CLEVELAND , May 27, 2015 /PRNewswire/ ... in medication safety systems and image documentation ... provider of comprehensive, technologically-advanced automation solutions, is ... art integration. The Codonics® Safe Label System® ... used in conjunction with the Omnicell Anesthesia ...
(Date:5/25/2015)... 25, 2015  Australia,s market for wearable technologies is ... saw the advent of several trials and prototypes. The ... is expected to ignite interest in wearables as well ... Australia . This in turn will spur greater ... new partnerships amongst vendors and distributors. ...
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3
Other Contents